Increasing activity in a deep-brain region can boost the immune system’s response to vaccines—and people can be trained to do ...
A large-scale clinical trial has determined that a specific brain stimulation device, previously cleared by regulators for ...
BOSTON--(BUSINESS WIRE)--Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback